The U.S. Supreme Court has declined to hear an appeal by Zimmer Biomet Holdings (ZBH +0.6%) over the tripling a $70M patent-infringement award to competitor Stryker (SYK -0.7%) related to devices that clean bones during surgery.
The final judgement was $230M based on ZBH’s “willful” infringement.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.